Search by Drug Name or NDC
NDC 71335-0194-06 Butalbital, Acetaminophen, Caffeine and Codeine Phosphate 325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1 Details
Butalbital, Acetaminophen, Caffeine and Codeine Phosphate 325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1
Butalbital, Acetaminophen, Caffeine and Codeine Phosphate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE.
MedlinePlus Drug Summary
This combination of drugs is used to relieve tension headaches. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 71335-0194-06Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Acetaminophen, Butalbital, and Caffeine
Product Information
| NDC | 71335-0194 |
|---|---|
| Product ID | 71335-0194_05725e50-34b6-49d4-8022-cb204fcf8978 |
| Associated GPIs | 65991004100115 |
| GCN Sequence Number | 004149 |
| GCN Sequence Number Description | butalbit/acetamin/caff/codeine CAPSULE 50-325-30 ORAL |
| HIC3 | H3M |
| HIC3 Description | OPIOID,NON-SALICYL.ANALGESIC,BARBITURATE,XANTHINE |
| GCN | 70140 |
| HICL Sequence Number | 001713 |
| HICL Sequence Number Description | BUTALBITAL/ACETAMINOPHEN/CAFFEINE/CODEINE PHOSPHATE |
| Brand/Generic | Generic |
| Proprietary Name | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 325; 50; 40; 30 |
| Active Ingredient Units | mg/1; mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE |
| Labeler Name | Bryant Ranch Prepack |
| Pharmaceutical Class | Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS] |
| DEA Schedule | CIII |
| Marketing Category | ANDA |
| Application Number | ANDA076560 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71335-0194-06 (71335019406)
| NDC Package Code | 71335-0194-6 |
|---|---|
| Billing NDC | 71335019406 |
| Package | 15 CAPSULE in 1 BOTTLE (71335-0194-6) |
| Marketing Start Date | 2021-12-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |